{"cik":2104204,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"Alamar Biosciences, Inc.","units":{"USD":[{"start":"2025-01-01","end":"2025-03-31","val":619000,"accn":"0001193125-26-213424","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-08","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":1299000,"accn":"0001193125-26-343003","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-11"},{"start":"2025-04-01","end":"2025-06-30","val":680000,"accn":"0001193125-26-343003","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-11","frame":"CY2025Q2"},{"start":"2026-01-01","end":"2026-03-31","val":1467000,"accn":"0001193125-26-213424","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-08","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-30","val":4747000,"accn":"0001193125-26-343003","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-11"},{"start":"2026-04-01","end":"2026-06-30","val":3280000,"accn":"0001193125-26-343003","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-11","frame":"CY2026Q2"}]}}